Corporate giving
By supporting us, your organisation has the power to transform the lives of millions of rare disease patients and their families
There is great value in all corporates have to offer, from their time and services, to resources and financial support. Findacure is always eager to develop corporate relationships that are mutually beneficial. We welcome support in a wide variety of forms, recognising that each relationship is unique. We ensure complete transparency in all our corporate relationships, with flexible benefit packages dependant on the wishes of your company. Collaboration between charity and corporates is vital to successfully build a rare disease community that supports, informs, and works together for the betterment of all rare conditions. Together, we can transform the lives of millions of people who are living with a rare disease.
Don’t just take our word for it, meet Annabel from Costello Medical Consulting
“Our ongoing collaboration with Findacure has been, and continues to be, exceptionally rewarding and our staff that volunteer to work on this project obtain immense job satisfaction from the opportunity. It is a true pleasure to work with such an enthusiastic and passionate charity, who are playing an instrumental role in promoting collaboration and developing treatments for patients with rare diseases. The work we do together spans health economics, publications and design – allowing us to share a range of expertise and encouraging people from different teams within Costello Medical to work together. Furthermore, Findacure’s commitment to promoting interactions between stakeholders in the rare disease area is fantastic; their networking events and scientific conferences are the perfect place to meet others from industry, as well as those from the public sector, and they are an immensely valuable opportunity to hear from patients themselves.”

How do I get involved?
Grant giving and charitable donations
As a charitable organisation dedicated to transforming the lives of rare disease patients, we rely on the generosity of companies and organisations to fund our projects. Corporates can provide financial support with an unrestricted grant, specific funding for one of our projects below, or through their own Charity of the Year scheme.
Our empowerment projects have successfully transformed many struggling patient groups into confident experts in their condition and valuable partners in research, meaning that funding our work has an impact that is significantly greater than the cost.
We are incredibly grateful for donations of all sizes and would be delighted if your organisation would consider providing grant support to enable us to continue our vital work with rare disease patient groups. To discuss our projects and potential funding opportunities, please get in touch with our Fundraising Manager, Laura at [email protected].

Training workshops
Our day-long workshops are a great opportunity for patient groups to learn together about specific topics.

Webinars
Bitesize webinars offer practical, hands-on guidance for patient groups from the convenience of their homes.

Mentoring
Our mentoring programme provides one-to-one support for new patient groups or those facing a challenge.

E-learning portal
Our portal is an information hub for patient groups. It contains topic-specific guides, case studies, and forums.
Sponsorship
Networking events are an essential part of what we do; breaking down barriers between patients industry and researchers to promote interaction. Our networking events and conferences provide a space for all rare disease stakeholders to form new collaborations, share ideas, and spread awareness of rare diseases.
We offer sponsorship packages for the exciting events below and would be delighted if your organisation would like to get involved. By supporting us, you can show your support for the rare disease community, raise your company profile within the UK’s life-sciences industry, and reinforce your position as a key player in the rare disease sector. Our sponsorship packages vary to meet your needs and include benefits such as increased brand awareness and valuable networking opportunities. To discuss the benefits of supporting us, please get in touch with our Head of Operations, Mary Rose at [email protected].

Conferences
Marking Rare Disease Day, our annual conference explores the latest developments rare disease research, namely in drug repurposing.

Showcases
Our Showcase networking events highlight and celebrate rare disease progress in local regions. Look out for one coming to a city near you!

Essay competition
Our ‘Student Voice’ essay competition encourages the researchers and medics of the future to engage with rare disease issues.
Pro bono
Offering your services to Findacure is an incredibly valuable way your organisation can get involved with our work. Collaboration is at the heart of all we do and we welcome potential partnerships with companies from all backgrounds. Just some of the areas of particular benefit to us are legal, financial, marketing, fundraising, health economic, and clinical trial advice. Please contact our CEO, Rick at [email protected] to discuss potential pro bono support and collaboration opportunities.
Fundraising
We are incredibly grateful to be supported by the following corporate funders in 2020
2020 Corporate Partner
Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Their AI drug discovery platform leverages public and proprietary biomedical data and features the world’s leading knowledge graph for rare diseases.
Combining their technology with patient insights and drug discovery expertise, Healx’s mission is to advance 100 rare disease treatments towards the clinic by 2025.
Support of our patient empowerment programme
Support of The Student Voice Prize
Support of the Drug Repurposing for Rare Diseases Conference
Support of the Rare Disease Showcase Series
Unstricted funding
We are incredibly grateful to be supported by the following corporate funders in 2020
2020 Corporate Partner
Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Their AI drug discovery platform leverages public and proprietary biomedical data and features the world’s leading knowledge graph for rare diseases.
Combining their technology with patient insights and drug discovery expertise, Healx’s mission is to advance 100 rare disease treatments towards the clinic by 2025.
Support of our patient empowerment programme
Support of the Drug Repurposing for Rare Diseases Conference
Unstricted funding
A huge thank you to our previous corporate supporters
2019
Alexion
BioMarin
Bionical
Cambridge Health Research
Cello Health
Chiesi
Costello Medical Research
Dolon
Healx
Kudos Health
LifeArc
Linguamatics
PharmacoMedics
Pharnext
Roche
Sobi
SOM Biotech
Takeda
Transcrip
Whiskers LLP
2018
AbbVie
AKU Society
Alexion
Amgen
Bespak
Biomarin
Bionical
Cambridge Health Research
Celgene
Cello Health
Costello Medical Consulting
Cresset Re-pharm
Dolon
Elsevier
Healx
Kudos Health
LifeArc
Linguamatics
Novartis
Patanni Health
PharmaCo
PharmaMar
Pharnext
Rhythm
SOBI
Takeda
TranScrip
Ultragenyx
Vertex
Whiskers LLP
2017
Amgen
BioMarin
Bates Wells Braithwaite
Collaborative Drug Discovery
Comradis
Costello Medical Consulting
Cresset Repharm
GSK
High Force Research
Horizon Pharma
Illingworth Research Group
Kudos Health
LifeArc
Modern Tribe
MRC Technology
One Nucleus
Orphanet Journal of Rare Diseases
Oxford PharmaGenesis
PharmacoMedics
Sanofi Genzyme
Shire
Takeda
TranScrip
Vertex Pharmaceuticals
Whiskers LLP
White & Case
2016
Alexion
Comradis
Congenica
Costello Medical Consulting
Display Wizard
Domainex
Elsevier
Hogan Lovells
Information Forum
Labstract
Linguamatics
Little Cupcake Company
Little Robot
Napp Pharmaceuticals
New College of Humanities
One Nucleus
Oxford PharmaGenesis
Orphanet Journal of Rare Diseases
Pharmacomedics
Raptor
R&R Saggers
Sanofi Genzyme
SOBI
Sookio
Takeda
TranScrip
Wasps Legends
Whiskers LLP
White & Case LLP
2015
Congenica
Costello Medical Consulting
Diorama Studio
Elsevier
Genzyme
Hogan Lovells LLP
Labstract
Linguamatics
Numbers for Good
Oliver Wyman
Sony Mobile
Stone King LLP
TranScrip
White & Case LLP
Women Hack for Non-Profits
WorkSpace
2014
Hogan Lovells
London Business School
London School of Economics
Sanofi
White & Case